Microbot Medical (MBOT) Cash & Current Investments (2010 - 2026)

Microbot Medical's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $69.0 million for Q1 2026.

• Quarterly Cash & Current Investments rose 27.04% year-over-year to $69.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.0 million (up 27.04% YoY) and the FY2025 annual result came in at $74.7 million, up 1265.3% from the prior year.
• Cash & Current Investments was $69.0 million for Q1 2026 at Microbot Medical, down from $74.7 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $74.7 million in Q4 2025 and bottomed at $3.0 million in Q1 2023.
• A 5-year average of $23.9 million and a median of $8.2 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2023 — Cash & Current Investments plunged 76.3% — and 2025, when it surged 1781.44%.
• Microbot Medical's Cash & Current Investments stood at $8.2 million in 2022, then slumped by 51.65% to $4.0 million in 2023, then soared by 37.92% to $5.5 million in 2024, then jumped by 1265.3% to $74.7 million in 2025, then declined by 7.55% to $69.0 million in 2026.
• Business Quant data shows MBOT's Cash & Current Investments at $69.0 million in Q1 2026, $74.7 million in Q4 2025, and $73.5 million in Q3 2025.